Obesity and diabetes cure? CRISPR might be used to ‘silence’ key gene found in unhealthy fat

obesity

The gene FABP4 is highly active in adipose tissue and known to be a major contributor to obesity and related diseases like type 2 diabetes. Researchers at Hanyang University in Seoul have developed a way to silence the gene using a type of gene-editing technology called CRISPR interference.

When the researchers inhibited FABP4 in white adipose tissue—commonly known as the unhealthy white fat—they observed a reduction in lipid storage.

Then they tried it in mice that had been fed a high-fat diet, injecting them twice a week with the CRISPR interference system. The mice lost 20% of their body weight and showed reductions in inflammation and insulin resistance, the team reported in the journal Genome Research.

Related article:  When genetic engineering is the environmentally friendly choice

Researchers continue to look for weight-loss strategies that might be more effective than the current slate of FDA-approved drugs. Those products—Eisai’s Belviq, Nalpropion’s Contrave and Vivus’ Qsymia—have only been shown to reduce body weight by a small percentage.

The Hanyang University team is planning further studies to determine how best to translate their gene therapy to people with obesity. They believe that similar “precision gene-editing technology” could be used to treat other diseases.

Read full, original post: Could gene therapy be the solution to obesity and diabetes?

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend